Reuters logo
BRIEF-Vectura gets $3 mln milestone for VR315 progress in US
March 25, 2014 / 7:11 AM / 4 years ago

BRIEF-Vectura gets $3 mln milestone for VR315 progress in US

March 25 (Reuters) - Vectura Group PLC : * Gets $3 million milestone associated with the development of VR315 in the US * VR315 is generic copy of GlaxoSmithKline’s $8 billion-a-year inhaled lung drug Advair * Source text for Eikon: * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below